Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Pharma
‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters
AstraZeneca and Bristol Myers Squibb do not have any ongoing discussions about a potential deal, Reuters reported Wednesday.
Angus Liu
Aug 5, 2026 10:12am
Fierce Biotech
Curium strikes up to $8B deal for radiopharma rival Lantheus
Aug 3, 2026 2:20pm
Supernus-Indivior merger is about scale, business development
Aug 3, 2026 11:20am
Editor’s Corner: Why an AZ-BMS merger would be a very bad idea
Aug 3, 2026 12:25am
Real Chemistry snaps up Spurwing Communications
Jul 7, 2026 7:31am
Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months
Jun 30, 2026 6:00am